Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05300737 · ClinicalTrials.gov registry record
Symptomatic Carotid Outcomes Registry
A clinical trial of Ischemic Stroke and Carotid Stenosis, sponsored by University of Maryland, Baltimore.
- Active
- Registry status
- 114
- Enrollment target
- 18
- Study locations
NCT05300737: Active study of Ischemic Stroke and Carotid Stenosis, sponsored by University of Maryland, Baltimore.
NCT05300737 is a study of Ischemic Stroke and Carotid Stenosis that is active but no longer recruiting, run by University of Maryland, Baltimore. The registered enrollment target is 114 participants, below the 1,462-participant average among 66 other Ischemic Stroke trials with a reported enrollment target (92% lower). The trial reports 18 study locations across 14 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05300737, a study of Ischemic Stroke and Carotid Stenosis, is active but no longer recruiting, sponsored by University of Maryland, Baltimore.
- ACTIVE NOT RECRUITING
- Registry status
- 114 participants
- Enrollment target
- 18
- Study locations
Study Summary
The purpose of this study is to build upon trials done over 30 years ago, which did not include statins, new antiplatelet agents, and newer antihypertensive medications. Since the landmark trials (NASCET, ECST), there have been new developments in medical stroke prevention, which creates a gap in knowledge. The aim of this study is to evaluate that clinical care with Intensive Medical Therapy (IMT) alone, the one year stroke rate in patients with symptomatic carotid stenosis and low risk clinical features will be \<5%.
Primary Outcome
ipsilateral to carotid stenosis, with radiologic confirmation
Conditions Studied
Interventions
- OTHER intensive medical therapy
Study Locations (18)
Illinois
- Northwestern Memorial Hospital - Chicago
- Rush Medical Center - Chicago
Massachusetts
- Baystate Medical Center - Springfield
- University of Massachusetts Medical Center - Worcester
Alberta
- Calgary Health Sciences Center - Calgary
- University of Alberta - Edmonton
Ontario
- Northern Ontario School of Medicine - Greater Sudbury
- Western University/London Health Sciences Center - London
Connecticut
- Hartford Hospital - Hartford
Georgia
- Emory University Hospital - Atlanta
Iowa
- University of Iowa - Iowa City
Maryland
- University of Maryland Medical Center - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 114 participants |
| Start Date | 2022-08-01 |
| Est. Completion | 2026-12 |
What the registry record for NCT05300737 still lists
NCT05300737 is an observational study that tracks outcomes without assigning an intervention. The registered 114 participants enrollment target is mid-sized for trials with a published cap, below the 1,462-participant average among 66 other Ischemic Stroke trials with a reported enrollment target (92% lower).
The record links to 3 conditions, with Ischemic Stroke appearing as the primary indexed condition, and to 1 intervention - of which intensive medical therapy is the first listed.
NCT05300737 lists 18 locations in 14 states (Illinois, Massachusetts, Alberta).
Frequently Asked Questions
What is clinical trial NCT05300737 about?
NCT05300737 is a clinical study titled "Symptomatic Carotid Outcomes Registry". The purpose of this study is to build upon trials done over 30 years ago, which did not include statins, new antiplatelet agents, and newer antihypertensive medications. Since the landmark trials (NASCET, ECST), there have been new developments in medical stroke prevention, which creates a gap in kn...
What is the current status of trial NCT05300737?
This trial is currently active not recruiting. The enrollment target is 114 participants. The study started on 2022-08-01. Estimated completion is 2026-12.
What conditions does trial NCT05300737 study?
This clinical trial studies the following conditions: Ischemic Stroke, Carotid Stenosis, Transient Ischemic Attack.
What interventions are being tested in trial NCT05300737?
The interventions under investigation include: intensive medical therapy (OTHER).
Who is sponsoring clinical trial NCT05300737?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05300737 being conducted?
This trial has 18 study locations across Connecticut, Georgia, Illinois, Iowa, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ischemic Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05300737's enrollment target sits among peer trials
114 30th of 66 higher than 37 of 66 other Ischemic Stroke trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Ischemic Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study Of Vagus Nerve Stimulation (VNS) With Mobility Training For Gait Recovery After Chronic Ischemic Stroke
RECRUITING · NA
-
Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on RecoverY
RECRUITING
-
Transitions of Care for Stroke Patients
RECRUITING
-
Personalized Transcranial Direct Current Stimulation in Stroke Recovery
RECRUITING · NA
-
Combined Thrombectomy for Distal MediUm Vessel Occlusion StroKe
RECRUITING · NA
-
Transcranial Direct Current Stimulation and Rehabilitation to Ameliorate Impairments in Neurocognition After Stroke
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04522791 · 114 participants · Phase 2
Breathing, Relaxation, Attention Training, & Health in Older Adults (BREATHE)
- NCT04875052 · 114 participants · NA
Vibration and Post-traumatic Osteoarthritis Risk Following ACL Injury
- NCT05100342 · 114 participants
Prospective Validation of a Points Score System Predicting 30-day Survival
- NCT05224089 · 114 participants · Phase 4
Bilateral TAP and RS Blocks Using Liposomal Bupivacaine/Bupivacaine vs. Regular Bupivacaine in Laparoscopic Colectomy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI